Ted Omlid is a senior managing director in the firm’s healthcare strategic advisory business and leads the healthcare technology practice. Mr. Omlid has over 15 years of experience advising a broad range of public and private healthcare technology and software companies and private equity firms.
Notable advisory experience includes ResMed on its acquisition of MEDIFOX DAN; Bain Capital on its growth investment in LeanTaaS; Intelligent Medical Objects on its sale to Thomas H. Lee Partners; Vocera Communications on its sale to Stryker; athenahealth on its sale to Hellman & Friedman and Bain Capital; Nuance Communications on its sale to Microsoft; Fortive on its acquisitions of Provation Software and Censis Technologies; Advent International on its strategic investment in Iodine Software; special committee of Inovalon on sale to Nordic Capital; Royal Philips on its acquisitions of Capsule Technologies and BioTelemetry; Leonard Green & Partners on its investment in WellSky; QGenda on its strategic growth investment from ICONIQ Capital; and Definitive Healthcare on its strategic investment from Advent.
Prior to joining Evercore in 2013, Mr. Omlid was an executive director at J.P. Morgan in the healthcare group.
He earned a B.S. in finance from Miami University and an MBA from the University of Michigan.